Julie R. Ostberg

Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy

Christine E. Brown, Darya Alizadeh, Renate Starr et al. · New England Journal of Medicine · 2016 · 1.8K citations · Full text

Cell Therapy, Immunology, Immune Regulation +17

Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma

Christine E. Brown, Behnam Badie, Michael E. Barish et al. · Clinical Cancer Research · 2015 · 733 citations · Full text

Adoptive Transfer of Chimeric Antigen Receptor Re-directed Cytolytic T Lymphocyte Clones in Patients with Neuroblastoma

Julie R. Park, David DiGiusto, Marilyn L. Slovak et al. · Molecular Therapy · 2007 · 593 citations · Full text

A transgene-encoded cell surface polypeptide for selection, in vivo tracking, and ablation of engineered cells

Xiuli Wang, Wen-Chung Chang, ChingLam W. Wong et al. · Blood · 2011 · 589 citations · Full text

Antitransgene Rejection Responses Contribute to Attenuated Persistence of Adoptively Transferred CD20/CD19-Specific Chimeric Antigen Receptor Redirected T Cells in Humans

Michael C. Jensen, Leslie Popplewell, Laurence J.N. Cooper et al. · Biology of Blood and Marrow Transplantation · 2010 · 517 citations · Full text